1332365-10-2

Basic information

• Product Name: ethyl (1R,3S)-3-(4-cyanophenylamino)cyclopentanecarboxylate
• Synonyms: ethyl (1R,3S)-3-(4-cyanophenylamino)cyclopentanecarboxylate
• CAS NO: 1332365-10-2
• Molecular Weight: 258.32
• Mol File: 1332365-10-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl (1R,3S)-3-(4-cyanophenylamino)cyclopentanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (1R,3S)-3-(4-cyanophenylamino)cyclopentanecarboxylate(1332365-10-2)
• EPA Substance Registry System: ethyl (1R,3S)-3-(4-cyanophenylamino)cyclopentanecarboxylate(1332365-10-2)

Safety Data

• Hazardous Substances Data: 1332365-10-2(Hazardous Substances Data)

Upstream product

• 71830-08-5 (1R,3S)-3-aminocyclopentanecarboxylic acid 
• 64-17-5 ethanol 
• 1311203-74-3 (1R,3S)-3-(4-cyanophenylamino)cyclopentanecarboxylic acid 
• 1194-02-1 4-fluorobenzonitrile 

Downstream Products

• 1311231-63-6 (1R,3S)-3-[4-{5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl}phenylamino]cyclopentanecarboxylic acid 
• 1312023-76-9 C₁₅H₂₁N₃O₃ 
• 1398512-07-6 C₂₄H₂₉ClN₄O₅ 
• 1332365-13-5 ethyl (1R,3S)-3-[4-{5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl}phenylamino]cyclopentanecarboxylate 
• 1312023-76-9 ethyl (1R,3S)-3-[4-(N-hydroxycarbamimidoyl)phenylamino]cyclopentanecarboxylate 
• 1398512-07-6 C₂₄H₂₉ClN₄O₅ 
• 1311232-74-2 (1R,3S)-3-{4-[5-(4-cyclohexyl-phenyl)-[1,2,4]oxadiazol-3-yl]-2-methyl-phenylamino}-cyclopentanecarboxylic acid 
• 1311232-73-1 (1R,3S)-3-[4-(5-biphenyl-4-yl-[1,2,4]oxadiazol-3-yl)-2-methyl-phenylamino]-cyclopentanecarboxylic acid 
• 1311232-72-0 (1R,3S)-3-[4-(5-biphenyl-3-yl-[1,2,4]oxadiazol-3-yl)-2-methyl-phenylamino]-cyclopentanecarboxylic acid 
• 1311232-71-9 (1R,3S)-3-[4-(5-biphenyl-2-yl-[1,2,4]oxadiazol-3-yl)-2-methyl-phenylamino]-cyclopentanecarboxylic acid 
• 1311258-51-1 (1R,3S)-3-{4-[5-(4-cyclohexyl-phenyl)-[1,2,4]oxadiazol-3-yl]-2-methyl-phenylamino}-cyclopentanecarboxylic acid ethyl ester 
• 1311258-50-0 (1R,3S)-3-[4-(5-biphenyl-4-yl-[1,2,4]oxadiazol-3-yl)-2-methyl-phenylamino]-cyclopentanecarboxylic acid ethyl ester 
• 1311258-49-7 (1R,3S)-3-[4-(5-biphenyl-3-yl-[1,2,4]oxadiazol-3-yl)-2-methyl-phenylamino]-cyclopentanecarboxylic acid ethyl ester 
• 1311258-48-6 (1R,3S)-3-[4-(5-biphenyl-2-yl-[1,2,4]oxadiazol-3-yl)-2-methyl-phenylamino]-cyclopentanecarboxylic acid ethyl ester 

Relevant articles and documents

Development of a scalable synthesis of oxadiazole based S1P1 receptor agonists

A robust and scalable synthesis was developed for the preparation of oxadiazole based S1P1 inhibitors. A new method for the separation of triphenylphosphine oxide from reaction products and an improved method for the synthesis of oxadiazoles in the presence of DBU were incorporated into the process to achieve its scalability.

NOVEL OXADIAZOLE COMPOUNDS

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o